KRMD Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 188.68
- PEG ratio
- —
- P/B
- 11.16
- P/S (TTM)
- 4.36
- EV/EBITDA
- -17.15
Profitability & growth
- ROE (TTM)
- -13.7%
- Operating margin
- -7.3%
- Revenue growth YoY
- 22.1%
- Dividend yield
- —
- Beta
- 0.41
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Repro Med Systems Inc
Company profileRepro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company is headquartered in Chester, New York.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 100 CORPORATE DRIVE, MAHWAH, NJ
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
